Biofidelity

Biofidelity is a genomic technology company focused on improving cancer patient outcomes through precision medicine. They offer ASPYRE-Lung, a novel test that simplifies and accelerates the detection of biomarkers for non-small cell lung cancer, enabling faster and more cost-effective treatment decisions. The company aims to bring the benefits of precision medicine to patients worldwide.

Buy Funded Startups lists

Funding Round: Series A+

Funding Amount: $24M

Date: 03-Apr-2024

Investors: Agilent Technologies, Octopus Ventures, BlueYard Capital, Longwall Ventures

Markets: Genomics, Healthcare, Biotechnology, Oncology

HQ: Cambridge, Cambridgeshire, United Kingdom

Founded: 2019

Website: https://www.biofidelity.com/

LinkedIn: https://www.linkedin.com/company/biofidelity

Twitter: https://twitter.com/biofidelity_dx

Instagram: